SPEAKER_04

We thought, you know what?

AI is moving so fast.

Why don't we just give this to the community?

Why don't we open source this?

We can use it for maybe specific targeted purposes, but we're basically going to publish the whole thing on GitHub to let other people use it.

Because we've seen other people make claims about stuff that they've already made, and it's like, oh, ours is better.

So why don't we just put it on GitHub and let people learn from it?

So back when I was a grad student in the 80s, basic research as opposed to translational research –

was considered the height of intellectual desire, right?

Basic research and we're not here to make money.

We're here to discover things.

And that's important.

And nearly every major discovery and every major therapy in the world came from basic research.

But then, you know, there were limits to how much money you could give to basic research.

And then there was a desire at a certain point to say, hey, are you going to do anything about this?

You know, are you going to make it?

And so translational research became a push.

So this guy at Stanford by the name of Paul Berg, who won the Nobel Prize for recombinant DNA way back in the day,

And Paul came up with this concept, bench to bedside, meaning that we don't have to be either or.

We can be part of an arc.